Cite
MLA Citation
JR Curtis et al.. “AB0235 Effect of baseline disease activity on achieving sustained low disease activity in baricitinib phase 3 studies.” Annals of the rheumatic diseases, vol. 76, n.d., pp. 1130–1131. http://access.bl.uk/ark:/81055/vdc_100135137873.0x00005d